banner add

New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs

Researchers at the University of Pittsburgh gave transplant recipients certain immune cells from their organ donors. It didn’t always work.

from NYT > Health https://ift.tt/4YH36LO
via IFTTT

No comments

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer

In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy. from NYT > Health ...

Theme images by PLAINVIEW. Powered by Blogger.